Table 2 Microorganisms isolated in exacerbations
From: Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations
Microorganism Isolated | Total No. 241 (100) |
|---|---|
Pseudomonas aeruginosa | 51 (21.16) |
aMDR Pseudomonas aeruginosa | 16 (6.64) |
Methicillin susceptible Staphylococcus aureus | 11 (4.56) |
Methicillin resistant Staphylococcus aureus | 6 (2.49) |
Acinetobacter sp | 3 (1.24) |
Moraxella catarrhalis | 7 (2.9) |
Stenotrophomonas maltophilia | 4 (1.66) |
Enterobacteriaceae | 12 (4.98) |
Escherichia coli | 5 (2.07) |
Proteus spp | 3 (1.24) |
Klebsiella pneumonia | 3 (1.24) |
Serratia spp | 1 (0.41) |
Haemophilus influenzae | 27 (11.2) |
Streptococcus pneumoniae | 25 (10.37) |
Achromobacter xylosoxidans | 5 (2.07) |
Mycoplasma pneumoniae | 6 (2.49) |
Chlamydia pneumoniae | 1 (0.41) |
Atypical mycobacteria | 4 (1.66) |
Aspergillus spp | 12 (4.98) |
Candida spp | 15 (6.22) |
Virus | 25 (10.37) |
Coronavirus | 1 (0.41) |
Metapneumovirus | 4 (1.65) |
Rhinovirus | 10 (4.14) |
Influenza A | 3 (1.24) |
Influenza B | 2 (0.82) |
Parainfluenza 3 | 2 (0.82) |
Respiratory Syncytial virus | 3 (1.24) |
Others | 11 (4.56) |